CeQur Simplicity, an insulin patch that adheres to the body, receives FDA clearance extending wear-time from four to seven days. While this is not an insulin pump, it’s wearability now extends past several mainstream infusion sets, creating less waste and reducing the burden on users. The FDA also cleared a new one-unit version of the device allowing for more precise meal-time dosing, whereas the previous versions delivered two-unit doses.

CeQur Simplicity is a thin, lightweight, discreet, wearable patch with a soft cannula that’s injected into the skin. The device holds up to 200 units of insulin and is made of soft, low profile material. An insulin dose is delivered by clicking the buttons on the side of the device. Simplicity is meant for meal-time dosing and corrections in conjunction with long-acting insulin; a replacement for multiple daily injections (MDI).

We spoke with the CeQur CEO on the podcast and learned about the device history, how it works, estimated out-of-pocket costs, and future plans. We also spoke with a CeQur Simplicity user on his experience using the device and how it’s been an integral tool in managing his diabetes management.

Would you use this device in lieu of mealtime insulin injections? Let us know in the comments!

Disclaimer: Diabetech content is not medical advice—it’s for educational purposes only. Always consult with a healthcare team before making changes to your treatment.